Last update: Oct. 19, 2014
Minimal risk for breastfeeding and infant.
R Isomer of Lansoprazole with similar pharmacokinetics.
At latest update, relevant information on excretion into breast milk was not found.
Due to a high serum-protein-binding capacity, excretion of Lansoprazole into breast milk is non-significant.
Since it's neutralized by the acid pH of stomach, capsules with enteric coated granules are used. Because of this, it is thought that the small quantity of Lansoprazole that may reach the breast milk would be neutralized by infant's stomach. In addition, absorption is greatly decreased by the presence of food.
Both Omeprazole and Pantoprazole pertain to the same chemical group with similar pharmacokinetics that are excreted in non-significant amount into the breast milk.
Medication that has been used for treatment of newborn and premature infants.
Hyperprolactinemia and galactorrhea have been reported by the use of such medication, though some authors have failed to show the same findings.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Confederación Nacional de Pediatría (CONAPEME) from Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM